Biogen: EU Approves Qalsody To Treat Rare, Genetic Form Of Amyotrophic Lateral Sclerosis

WESTON (dpa-AFX) - Biogen Inc. (BIIB) said that the European Commission has granted marketing authorization under exceptional circumstances and maintained orphan designation for Qalsody (tofersen)

Related Keywords

United States , ,European Union ,More Such Health News ,Biogen Inc ,Ionis Pharmaceuticals Inc ,European Commission ,Ionis Pharmaceuticals ,Ihr Portfolio ,